These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 34616769)
1. Testicular Nuclear Receptor 4 Regulates Proliferation and Apoptosis of Bladder Cancer Wang H; Luo W; Wang X; Xue D; Ren L; Xu L; Ge G; Xia L; Yu S; Wang M; Zhou Z; Li G; Wu H Front Mol Biosci; 2021; 8():670409. PubMed ID: 34616769 [TBL] [Abstract][Full Text] [Related]
2. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth. Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071 [TBL] [Abstract][Full Text] [Related]
3. TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Kim E; Ma WL; Lin DL; Inui S; Chen YL; Chang C Biochem Biophys Res Commun; 2007 Sep; 361(2):323-8. PubMed ID: 17655826 [TBL] [Abstract][Full Text] [Related]
4. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression. Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838 [TBL] [Abstract][Full Text] [Related]
5. Di-(2-ethylhexyl) phthalate induces apoptosis of GC-2spd cells via TR4/Bcl-2 pathway. Zhu L; Lu J; Tang X; Fu G; Duan P; Quan C; Zhang L; Zhang Z; Chang W; Shi Y Environ Toxicol Pharmacol; 2016 Jun; 44():18-24. PubMed ID: 27084994 [TBL] [Abstract][Full Text] [Related]
6. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype. Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287 [TBL] [Abstract][Full Text] [Related]
7. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling. Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468 [TBL] [Abstract][Full Text] [Related]
8. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling. Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852 [TBL] [Abstract][Full Text] [Related]
9. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells. Lin SJ; Yang DR; Wang N; Jiang M; Miyamoto H; Li G; Chang C Oncoscience; 2015; 2(2):142-50. PubMed ID: 25859557 [TBL] [Abstract][Full Text] [Related]
10. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status. Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376 [TBL] [Abstract][Full Text] [Related]
11. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer. Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291 [TBL] [Abstract][Full Text] [Related]
12. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals. Bai J; Yeh S; Qiu X; Hu L; Zeng J; Cai Y; Zuo L; Li G; Yang G; Chang C Oncogene; 2018 Nov; 37(44):5901-5912. PubMed ID: 29973687 [TBL] [Abstract][Full Text] [Related]
13. TR2 and TR4 Orphan Nuclear Receptors: An Overview. Lin SJ; Yang DR; Yang G; Lin CY; Chang HC; Li G; Chang C Curr Top Dev Biol; 2017; 125():357-373. PubMed ID: 28527578 [TBL] [Abstract][Full Text] [Related]
14. TR4 worsen urosepsis by regulating GSDMD. Wang H; Zhu S; Zhou Z; Wang Z; Zhuang W; Xue D; Lu Z; Zheng Q; Ding L; Ren L; Luo W; Wang R; Ge G; Xia L; Li G; Wu H Eur J Med Res; 2024 Mar; 29(1):151. PubMed ID: 38429762 [TBL] [Abstract][Full Text] [Related]
15. Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma. Chen Y; Lu J; Xia L; Xue D; Yu X; Shen D; Xu L; Li G Cancer Sci; 2018 Feb; 109(2):384-394. PubMed ID: 29197138 [TBL] [Abstract][Full Text] [Related]
16. Differential roles of PPARĪ³ vs TR4 in prostate cancer and metabolic diseases. Liu S; Lin SJ; Li G; Kim E; Chen YT; Yang DR; Tan MH; Yong EL; Chang C Endocr Relat Cancer; 2014 Jun; 21(3):R279-300. PubMed ID: 24623743 [TBL] [Abstract][Full Text] [Related]
17. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524 [TBL] [Abstract][Full Text] [Related]
18. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals. Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427 [TBL] [Abstract][Full Text] [Related]
19. Targeting the ERK pathway for the treatment of Cushing's disease. Zhang D; Bergsneider M; Wang MB; Heaney AP Oncotarget; 2016 Oct; 7(43):69149-69158. PubMed ID: 27708250 [TBL] [Abstract][Full Text] [Related]